source
- FDA signals upcoming rules for generative AI use in drug developmentThe FDA announced it intends to create regulatory guidance for the use of generative artificial intelligence in pharmaceutical research and development. The move follows growing interest in AI too…
- Aon warns 2027 will bring steep rise in employer health premiums, highlighting data gaps for public-sector plansAon’s chief actuary warned that 2026 data points to a harsh 2027 for employer-sponsored health insurance premiums, with costs expected to rise sharply. The firm said employers will need better dat…